You just read:

IONIS-HTT Rx (RG6042) Top-Line Data Demonstrate Significant Reductions of Disease-Causing Mutant Huntingtin Protein in People with Huntington's Disease

News provided by

Ionis Pharmaceuticals, Inc.

Mar 01, 2018, 16:30 ET